Brief: Enliven Therapeutics Prices 8.9 Million Shares At $37.50 Per Share
12/06/2026 03:41
BRIEF-Enliven Therapeutics Prices 8.9 Million Shares At $37.50 Per Share June 11 (Reuters) - Enliven Therapeutics Inc ELVN.O:
ENLIVEN THERAPEUTICS ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
ENLIVEN: PRICES 8.9 MILLION SHARES AT $37.50 PER SHARE
Source text: ID:nPn5NTJDsa
Further company coverage: ELVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses